Français
ItalianoBond Amgen 4.2% ( US031162DV90 ) in USD
| Issuer | Amgen | ||||||
| Market price |  100.08 % ▲ |
||||||
| Country |  United States
|
||||||
| ISIN code |
 US031162DV90 ( in USD )
|
||||||
| Interest rate | 4.2% per year ( payment 2 times a year) | ||||||
| Maturity | 19/02/2031 | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | / | ||||||
| Total amount | / | ||||||
| Cusip | 031162DV9 | ||||||
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) | ||||||
| Moody's rating | Baa1 ( Lower medium grade - Investment-grade ) | ||||||
| Next Coupon | 19/02/2027 ( In 158 days ) | ||||||
| Detailed description |
Amgen is a leading biotechnology company focused on developing and delivering innovative therapies for serious illnesses in areas such as oncology, cardiovascular disease, and inflammation. The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162DV90, pays a coupon of 4.2% per year. The coupons are paid 2 times per year and the Bond maturity is 19/02/2031 The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162DV90, was rated Baa1 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162DV90, was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||